
CT-guided procedures remain an important tool for diagnosis and tissue acquisition for primary diagnosis and molecular/tissue correlation. New imaging devices such as MDCT and PET/CT will improve diagnosis but percutaneous procedures will be needed to confirm and support new molecular and DNA treatments. Coagulopathic patients can be treated with LIBE a new method to prevent bleeding. Vasoactive drugs can be used to improve differentiation of malignant and benign diseases.

